CEACAM5 and colorectal carcinoma: Together with other markers, the carcinoembryonic antigen is used in the surveillance of CRC patients as a clinical parameter for prognosis determination (Duffy, 2001; Goldstein and Mitchell, 2005; Thomson et al., 1969).